Salute e Benessere
IBA – Regulated information
November 7 , 2025
Under this provision:
As of today :
for threshold crossing notifications: shareholderrelations@iba-group.com.
: registered shares recorded in the share register for at least two consecutive years in the name of their holder (section 28 of the articles of association, in accordance with section 7:53 of the Companies and Associations Code).
Following the introduction of the loyalty voting right by decision of the general meeting of March 10, 2020, the calculation method used by IBA to determine the number of shares with the loyalty voting right at any time is the (last in, first out), namely: for the same registered shareholder, the shares which the latter most recently acquired are the first shares which will be deducted from his “basket” of registered shares if he transfer shares thereafter.
(section 7, paragraph 1, of the articles of association: “No shareholder may, with companies and persons related to him, participate in the voting at general meetings for a issued by the company”): currently , i.e. 14.180.116,65 votes.
: Euronext Brussels BE0003766806
IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the fields of proton therapy, considered as the most advanced form of radiation therapy available today, as well as industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 2,100 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.
IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).
More information can be found at: www.iba-worldwide.com
Attachment
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti